Pastushenko, I., & Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends in Cell Biology, 29(3), 212–226.
Hippo, Y., et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Research, 61(3), 889–895.
Bai, F. H., et al. (2012). Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray. Genetics & Molecular Research, 11(2), 1682–1689.
Kanda, M., & Kodera, Y. (2016). Molecular mechanisms of peritoneal dissemination in gastric cancer. World Journal of Gastroenterology, 22(30), 6829–6840.
Article PubMed PubMed Central Google Scholar
Rau, B., et al. (2020). Peritoneal metastasis in gastric cancer: Results from the German database. Gastric Cancer, 23(1), 11–22.
Koemans, W. J., et al. (2021). Synchronous peritoneal metastases of gastric cancer origin: Incidence, treatment and survival of a nationwide Dutch cohort. Gastric Cancer, 24(4), 800–809.
Lee, J. E., et al. (2023). Genomic and evolutionary characteristics of metastatic gastric cancer by routes. British Journal of Cancer, 129(4), 672–682.
Article PubMed PubMed Central Google Scholar
Ren, K., et al., Development of the peritoneal metastasis: A review of back-grounds, mechanisms, treatments and prospects. J Clin Med, 2022. 12(1).
Yonemura, Y., et al., The development of peritoneal metastasis from gastric cancer and rationale of treatment according to the mechanism. J Clin Med, 2022. 11(2).
Cristescu, R., et al. (2015). Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine, 21(5), 449–456.
Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases and Sciences, 52(6), 1571–1578.
Wang, R., et al. (2020). Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut, 69(1), 18–31.
Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases & Sciences, 52(6), 1571–1578.
Li, F., et al. (2018). S100A4-MYH9 axis promote migration and invasion of gastric cancer cells by inducing TGF-beta-mediated epithelial-mesenchymal transition. Journal of Cancer, 9(21), 3839–3849.
Article PubMed PubMed Central Google Scholar
Yonemura, Y., et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clinical Cancer Research, 6(11), 4234–4242.
Pan, T., et al. (2021). Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids, 23, 1288–1303.
Article PubMed PubMed Central Google Scholar
Kurashige, J., et al. (2015). Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Carcinogenesis, 36(1), 133–141.
Jiang, T., et al., FNDC1 promotes the invasiveness of gastric cancer via Wnt/beta-catenin signaling pathway and correlates with peritoneal metastasis and prognosis. Frontiers in Oncology, 2020. 10 (no pagination).
Sasahara, M., et al. (2021). Tissue RNFT2 expression levels are associated with peritoneal recurrence and poor prognosis in gastric cancer. Anticancer Research, 41(2), 609–617.
Sawaki, K., et al. (2018). Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer. Annals of Surgical Oncology, 25(7), 2083–2090.
Shimura, T., et al. (2021). Genomewide expression profiling identifies a novel miRNA-based signature for the detection of peritoneal metastasis in patients with gastric cancer. Annals of Surgery, 274(5), e425–e434.
Zang, M., et al. (2014). CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. PLoS ONE, 9(11), e112908.
Article PubMed PubMed Central Google Scholar
Takei, Y., et al. (2020). Long noncoding RNA HOTAIR promotes epithelial-mesenchymal transition and is a suitable target to inhibit peritoneal dissemination in human scirrhous gastric cancers. Pathobiology, 87(5), 277–290.
Yu, Z., et al. (2019). Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M. Gastric Cancer, 22(5), 955–966.
Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular & Molecular Medicine, 25(4), 2238–2253.
Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular and Molecular Medicine, 25(4), 2238–2253.
Article PubMed PubMed Central Google Scholar
Peng, Z., et al. (2014). Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World Journal of Gastroenterology, 20(18), 5403–5410.
Article PubMed PubMed Central Google Scholar
Zhang, D. Z., et al. (2017). Basic transcription factor 3 is required for proliferation and epithelial-mesenchymal transition via regulation of FOXM1 and JAK2/STAT3 signaling in gastric cancer. Oncology Research, 25(9), 1453–1462.
Article PubMed PubMed Central Google Scholar
Wu, X., et al. (2017). IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget, 8(13), 20741–20750.
Article PubMed PubMed Central Google Scholar
Kim, M. A., et al. (2009). Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology, 54(4), 442–451.
Ge, Q., et al. (2020). Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition. The FASEB Journal, 34(2), 2161–2172.
Wu, S., et al. (2017). AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression. Journal of Cellular and Molecular Medicine, 21(12), 3481–3493.
Article PubMed PubMed Central Google Scholar
Carino, A., et al. (2016). The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget, 7(38), 61021–61035.
Article PubMed PubMed Central Google Scholar
Toiyama, Y., et al., Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer. Journal of Clinical Oncology. Conference, 2011. 29(4 SUPPL. 1).
Zhou, Q., et al. (2020). The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-alpha/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene, 39(7), 1414–1428.
Chen, B., et al., H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clin Transl Med, 2023. 13(11): p. e1481.
Zhang, Z., et al. (2020). A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos. Journal of Cellular and Molecular Medicine, 24(24), 14217–14230.
Article PubMed PubMed Central Google Scholar
Jiang, J., et al. (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30(44), 4498–4508.
Article PubMed PubMed Central Google Scholar
Tokuyama, J., et al. (2005). Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Anticancer Research, 25(1A), 17–22.
Comments (0)